Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00534157 · ClinicalTrials.gov registry record

Study of Eye Pressure as a Predictor of Intracranial Pressure in the Acutely Head-Injured Population

A clinical trial of Craniocerebral Trauma, sponsored by Ohio State University.

Completed
Registry status
37
Enrollment target
1
Study location

NCT00534157: Completed study of Craniocerebral Trauma, sponsored by Ohio State University.

NCT00534157 is a study of Craniocerebral Trauma that has completed, run by Ohio State University. The registered enrollment target is 37 participants, below the 208-participant average among 6 other Craniocerebral Trauma trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00534157, a study of Craniocerebral Trauma, has completed, sponsored by Ohio State University.

COMPLETED
Registry status
37 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if the pressure in the eye of a severely head-injured person correlates with the pressure in the person's skull. This is a prospective study of patients aged 18 and older who have experienced a traumatic closed head injury and are intubated either before or during the time they are in the Emergency Department (ED). Identified patients have an eye pressure measurement performed in the trauma bay by an OSU ED physician not involved in their care. Information about their hospital stay, including the first brain pressure measurement if a such a measuring device is used, will be collected. In addition, the outcome of their hospital stay will be recorded.

Conditions Studied

Study Locations (1)

Ohio

  • The Ohio State University Medical Center - Columbus

Trial Details

FieldValue
Enrollment Target 37 participants
Start Date 2004-06
Est. Completion 2007-04
Ohio State University

552 total trials

What the finished NCT00534157 record still lists

NCT00534157 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 37 participants, a relatively small participant target, below the 208-participant average among 6 other Craniocerebral Trauma trials with a reported enrollment target (82% lower).

The record links to 1 condition, with Craniocerebral Trauma appearing as the primary indexed condition, and to 0 interventions.

NCT00534157 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT00534157 about?

NCT00534157 is a clinical study titled "Study of Eye Pressure as a Predictor of Intracranial Pressure in the Acutely Head-Injured Population". The purpose of this study is to determine if the pressure in the eye of a severely head-injured person correlates with the pressure in the person's skull. This is a prospective study of patients aged 18 and older who have experienced a traumatic closed head injury and are intubated either before or ...

What is the current status of trial NCT00534157?

This trial is currently completed. The enrollment target is 37 participants. The study started on 2004-06. Estimated completion is 2007-04.

What conditions does trial NCT00534157 study?

This clinical trial studies the following conditions: Craniocerebral Trauma.

Who is sponsoring clinical trial NCT00534157?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00534157 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Craniocerebral Trauma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02800486 · 37 participants · Phase 2

    Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

  • NCT03173937 · 37 participants · Phase 1

    Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome

  • NCT03295227 · 37 participants · Phase 1

    Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer

  • NCT03401047 · 37 participants · Early Phase 1

    Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00534157, the US trial registry maintained by the National Library of Medicine. NCT00534157 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.